Biogen gets European approval for postpartum depression treatment

Go back to Biogen gets European approval for postpartum depression treatment
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 216.78 +2.43 (1.13%)
Previous Close $214.35    52 Week High $333.65 
Open $217.76    52 Week Low $223.02 
Day High $219.12    P/E 27.76 
Day Low $215.00    EPS $7.81 
Volume 722,348       

SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 45.85 -1.6 (3.37%)
Previous Close $47.45    52 Week High $26.84 
Open $47.71    52 Week Low $9.51 
Day High $47.82    P/E N/A 
Day Low $45.79    EPS $-2.62 
Volume 748,894